Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FZ0XX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $82,179
Award facts
- Contract value 100% obligated
- $82,178.55 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $82,178.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg dose in 2-pen/mL format on September 13, 2025, with completion scheduled for September 15, 2025. This is an unset-aside, competitively awarded contract with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger pharmaceutical supply framework with DLA.
This delivery order is issued against AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. Cosentyx, a biologic immunosuppressant used to treat conditions such as psoriasis and ankylosing spondylitis, is representative of the specialized medications within AmerisourceBergen's extensive federal contract portfolio. The company's consistent receipt of competitive awards reflects its demonstrated capability to meet stringent federal procurement requirements for critical medical commodities.
Quick answers
Who was awarded contract SPE2DB25FZ0XX?
SPE2DB25FZ0XX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 13, 2025.
How much is contract SPE2DB25FZ0XX worth?
The government has obligated $82,179 on SPE2DB25FZ0XX.
Is contract SPE2DB25FZ0XX an order under another contract?
Yes. SPE2DB25FZ0XX is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FZ0XX competed?
The extent of competition for SPE2DB25FZ0XX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award